Literature DB >> 27333769

[Pain reduction by topically applied capsaicin 8 % : For whom does it work?].

N M Malewicz1, T Mainka2, C Maier3.   

Abstract

Entities:  

Year:  2016        PMID： 27333769     DOI： 10.1007/s00482-016-0131-8

Source DB:  PubMed          Journal:  Schmerz        ISSN： 0932-433X            Impact factor:   1.107


× No keyword cloud information.
  9 in total

Review 1.  The vanilloid receptor: a molecular gateway to the pain pathway.

Authors:  M J Caterina; D Julius
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

2.  The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study.

Authors:  Dyveke T Demant; Karen Lund; Jan Vollert; Christoph Maier; Märtha Segerdahl; Nanna B Finnerup; Troels S Jensen; Søren H Sindrup
Journal:  Pain       Date:  2014-08-17       Impact factor: 6.961

3.  A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteers.

Authors:  William R Kennedy; Geertrui F Vanhove; Shiao-Ping Lu; Jeffrey Tobias; Keith R Bley; David Walk; Gwen Wendelschafer-Crabb; Donald A Simone; Mona M Selim
Journal:  J Pain       Date:  2010-04-18       Impact factor: 5.820

Review 4.  Mechanism- and experience-based strategies to optimize treatment response to the capsaicin 8% cutaneous patch in patients with localized neuropathic pain.

Authors:  R-D Treede; T Wagner; K-U Kern; I W Husstedt; G Arendt; F Birklein; T Cegla; R Freynhagen; H-H Gockel; M-L Heskamp; H Jager; R Joppich; C Maier; A Leffler; H-H Nagelein; R Rolke; S Seddigh; C Sommer; S Stander; G Wasner; R Baron
Journal:  Curr Med Res Opin       Date:  2013-03-21       Impact factor: 2.580

5.  Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control.

Authors:  Laszlo Karai; Dorothy C Brown; Andrew J Mannes; Stephen T Connelly; Jacob Brown; Michael Gandal; Ofer M Wellisch; John K Neubert; Zoltan Olah; Michael J Iadarola
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

6.  Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch.

Authors:  Annika B Malmberg; Andrew P Mizisin; Nigel A Calcutt; Thorsten von Stein; Wendye R Robbins; Keith R Bley
Journal:  Pain       Date:  2004-10       Impact factor: 6.961

Review 7.  Neuropathic pain assessment: update on laboratory diagnostic tools.

Authors:  Tina Mainka; Christoph Maier; Elena K Enax-Krumova
Journal:  Curr Opin Anaesthesiol       Date:  2015-10       Impact factor: 2.706

8.  Ablation of rat TRPV1-expressing Adelta/C-fibers with resiniferatoxin: analysis of withdrawal behaviors, recovery of function and molecular correlates.

Authors:  Kendall Mitchell; Brian D Bates; Jason M Keller; Matthew Lopez; Lindsey Scholl; Julia Navarro; Nicholas Madian; Gal Haspel; Michael I Nemenov; Michael J Iadarola
Journal:  Mol Pain       Date:  2010-12-17       Impact factor: 3.395

9.  Treatment of peripheral neuropathic pain by topical capsaicin: Impact of pre-existing pain in the QUEPP-study.

Authors:  C G Maihöfner; M-L S Heskamp
Journal:  Eur J Pain       Date:  2013-10-29       Impact factor: 3.931
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.